View More Recent Stories

May 12, 2022 07:05AM Virios Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update
May 5, 2022 07:05AM Virios Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on Thursday, May 12, 2022
Apr 28, 2022 07:05AM Virios Therapeutics Completes Enrollment of 425 Patients in Phase 2b “FORTRESS” Clinical Trial for Fibromyalgia
Mar 17, 2022 07:07AM Virios Therapeutics (VIRI) Reports Q4 Results, Provides Corporate Update
Mar 17, 2022 07:05AM Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Mar 10, 2022 07:05AM Virios Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Thursday, March 17, 2022
Mar 8, 2022 04:05PM Virios Therapeutics to Present at the 34th Annual Roth Conference on Monday, March 14, 2022
Feb 28, 2022 07:05AM Virios Therapeutics (VIRI) Enters Research Collaboration for Potential of Combination Antiviral Therapy for Treating Long COVID
Feb 28, 2022 07:05AM Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID
Aug 19, 2021 07:05AM Virios Therapeutics Announces New Social Media Profiles
View More Recent Stories